NeurologyWire

AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. Duopa is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube.It was appr...

Login to read story

Thursday, March 26, 2015

Show last days of articles

Long-Term Effect of DBS on Pain in Patients with Parkinson D...

From NeurologyWire

Patients with Parkinson disease who experienced pain before undergoing subthalamic nucleus deep brain stimulation (STN DBS) had that pain improved or ...Full story

Wednesday, March 25, 2015

Brain Sees New Words as Pictures After Learning Them

From NeurologyWire

When we look at a known word, our brain sees it like a picture, not a group of letters needing to be processed. Thats the finding from a Georgetown Un...Full story

Prophylactic AEDs Before Epilepsy Surgery Still Flummox Neur...

From NeurologyWire

New research finds little evidence to suggest that AED treatment administered prophylactically is effective or not effective in preventing post-cranio...Full story

FDA's Perspective on the New Antidepressant Vortioxetine

From NeurologyWire

An article published in the Journal of Clinical Psychiatry summarizes the Food and Drug Administration's (FDA's) approval of vortioxetine, a new antid...Full story

Meta-analysis: Dementia Screening Tool More Useful in Genera...

From NeurologyWire

A new meta-analysis suggests that the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) performs better in the general hospital set...Full story

Tuesday, March 24, 2015

Smell Test Could Determine Troops with TBI

From NeurologyWire

Decreased ability to identify specific odors can predict abnormal neuroimaging results in blast-injured troops, according to a new study by Federal re...Full story

FDA Grants Orphan Drug Status to ALS Treatment

From NeurologyWire

The Dutch company Treeway has won orphan drug status for its investigational treatment for ALS, the compound TW001.From PM Live"The orphan drug design...Full story

Blood Test Can Help Identify Stroke Risk Following Heart Sur...

From NeurologyWire

The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at...Full story

Report: Less Than Half of People with Alzheimer's Say They W...

From NeurologyWire

The Alzheimer's Association's 2015 Alzheimer's Disease Facts and Figures report, released today, found that only 45 percent of people with Alzheimer's...Full story

Monday, March 23, 2015

FDA Unsure if Schizophrenia Drug Caused Deaths

From NeurologyWire

The FDA was unable to determine whether the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate) caused two patients deaths.In a statem...Full story

FDA Lifts Breaks on Pain Drug Study

From NeurologyWire

Pfizer and Eli Lilly are preparing to resume the Phase III clinical trial for tanezumab after FDA lifted a partial hold on the pain drug. From Reuters...Full story

Friday, March 20, 2015

Who will develop memory problems? New tool may help predict

From NeurologyWire

Researchers have developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking p...Full story

Thursday, March 19, 2015

Researchers Identify Gene Linked with Early Epilepsy

From NeurologyWire

Certain types of early-onset epilepsy are caused by previously unknown mutations of a potassium channel gene, KCNA2. The mutations disrupt the electri...Full story

Parkinson's Sufferers More Than Twice as Likely to Die in Ho...

From NeurologyWire

The risk of dying in hospital for people with Parkinson's following an emergency admission is increased by almost 2.5 times with the risk for older su...Full story

Study: Use of Anti-Clotting Drug More Than 3 Hours After Str...

From NeurologyWire

Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in the Brit...Full story